Hatton JN, Frone MN, …, Bofill-De Ros X, et al. “Specifications of the ACMG/AMP variant curation guidelines for analysis of germline DICER1 variants”. Human Mutation (2023)

Yang A*, Bofill-De Ros X*, Stanton RC, et al. “TENT2, TUT4 and TUT7 selectively regulate miRNA sequence and abundance”. Nature Communications (2022)

Bofill-De Ros X#, Hong Z, Birkenfeld B, et al. “Flexible pri-miRNA structures enable tunable production of 5’ isomiR”. RNA Biology (2022)

Bofill-De Ros X#, Luke B, Guthridge R, et al. “Tumor IsomiR Encyclopedia (TIE): a pan-cancer database of miRNA isoforms”. Bioinformatics (2021)

Yang A*, Shao TJ*, Bofill-De Ros X*, Lian C, Villanueva P, Dai L, Gu S. “AGO-bound mature miRNAs are oligouridylated by TUTs and subsequently degraded by DIS3L2”. Nature Communications (2020)

Dai L, Hallmark L, Bofill-De Ros X, et al. “Novel, abundant Drosha isoforms are deficient in miRNA processing in cancer cells”. RNA Biology (2020)

Desvignes T, ..., Bofill-De Ros X, et al. “Unification of miRNA and isomiR research: the mirGFF3 format and the mirtop API”. Bioinformatics (2020)

Yang A*, Bofill-De Ros X*, et al. “3’ uridylation Confers miRNAs with novel non-canonical target repertoires”. Molecular Cell (2019)

Bofill-De Ros X, et al. “Structural differences between pri-miRNA paralogs promotes alternative Drosha cleavage and expands target repertoires”. Cell Reports (2019) – Cover story

Bofill-De Ros X, Chen K, et al. “QuagmiR: A cloud-based application for isomiR big data analytics”. Bioinformatics (2018)

Luna J*, Boni J*, Cuatrecasas M, Bofill-De Ros X, et al. “DYRK1A modulates c-MET in pancreatic ductal adenocarcinoma to drive tumour growth”. Gut (2018)

Rodríguez-Comas J, Moreno-Asso A, ..., Bofill-De Ros X, et al. “Stress-induced microRNA-708 impairs β-cell function and growth”. Diabetes (2017).

Bofill-De Ros X, Santos M, Vila M, et al. “Genome-wide miR-155 and miR-802 target gene identification in the hippocampus of Ts65Dn Down syndrome mouse model by miRNA sponges”. BMC Genomics (2015).

Bofill-De Ros X*, Villanueva E*, Fillat C. “Late-phase miRNA-controlled oncolytic adenovirus for selective killing of cancer cells”. Oncotarget (2015).

Bofill-De Ros X, Gironella M., Fillat C., “miR-148a and miR-216a regulated oncolytic adenoviruses targeting pancreatic tumors attenuate tissue damage without perturbation of miRNA activity”. Molecular Therapy (2014).